Your session is about to expire
← Back to Search
Exoskeleton
Powered Exoskeleton for Knee Osteoarthritis
N/A
Recruiting
Led By Ann M Spungen, EdD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
self-reported limitations to mobility and walking activities due to knee pain, stiffness, loss of range of motion
medical diagnosis of Grade 3 or 4 knee OA
Must not have
able to walk at a normal walking speed (>1.2 m/s) based on a 6-minute walk test (6MWT)
a score of <8/10 on the MacArthur Competence Assessment Tool for Treatment (MacCAT-T) (as a proxy for cognitive competency screening)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 15 minutes for each condition: 1) using the keeogo, 2) using the prescribed knee brace, and 3) using nothing on the knee (optional)
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether a robotic exoskeleton can help people with impaired mobility walk better than with standard knee braces.
Who is the study for?
This trial is for veterans with severe knee osteoarthritis (Grade 3 or 4) who experience pain and mobility limitations, have used a knee brace for at least three months, and struggle with activities like standing, walking, or climbing stairs. It's not suitable for those with neurological paralysis, normal walking speed, incompatible body measurements for the device, certain medical conditions (like cardiovascular issues), cognitive impairment as per MacCAT-T score <8/10, pregnancy/planning to become pregnant or joint contractures.
What is being tested?
The study tests the Keeogo robotic exoskeleton designed to assist knees during movement against standard knee braces. The goal is to see if it improves mobility outcomes in lab tests such as walk test and stair test; reduces pain; and increases user satisfaction among people with impaired mobility due to knee osteoarthritis.
What are the potential side effects?
While specific side effects are not listed here, potential risks may include discomfort from wearing the device, skin irritation where it contacts the body, muscle fatigue from new movement patterns or possible falls due to unfamiliarity with using an exoskeleton.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have difficulty moving or walking because of knee pain and stiffness.
Select...
I have severe knee arthritis.
Select...
I have been using a prescribed knee brace for over three months.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I can walk at a normal speed based on a test.
Select...
My cognitive ability to make treatment decisions is confirmed.
Select...
I cannot stand or walk due to paralysis.
Select...
I have stiff joints in my legs that limit my ability to move or sit.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 15 minutes for each condition: 1) using the keeogo, 2) using the prescribed knee brace, and 3) using nothing on the knee (optional)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 15 minutes for each condition: 1) using the keeogo, 2) using the prescribed knee brace, and 3) using nothing on the knee (optional)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Changes of 13-Step Stair Test results among different conditions
Changes of 6-Minute Walk Test results among different conditions
Changes of Pick Up Penny from Floor Test results among different conditions
+2 moreSecondary study objectives
Changes of Numeric Pain Rating Scale results among different conditions
System Usability Scale
Usefulness Satisfaction and Ease of Use Questionnaire
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Knee OA groupExperimental Treatment1 Intervention
Individuals who are over 18 years and have medical diagnosis of Grade 3 or 4 knee OA
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Keeogo
2017
N/A
~20
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,664 Previous Clinical Trials
3,765,571 Total Patients Enrolled
22 Trials studying Osteoarthritis
3,778 Patients Enrolled for Osteoarthritis
VA Pittsburgh Healthcare SystemFED
34 Previous Clinical Trials
13,200 Total Patients Enrolled
Ann M Spungen, EdDPrincipal InvestigatorJames J. Peters Veterans Affairs Medical Center
6 Previous Clinical Trials
851 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can walk at a normal speed based on a test.You are pregnant or trying to become pregnant.I have difficulty moving or walking because of knee pain and stiffness.I don't have health issues that prevent me from wearing a device or walking.My cognitive ability to make treatment decisions is confirmed.I cannot stand or walk due to paralysis.Your body size is not compatible with the device being used in the study.I have stiff joints in my legs that limit my ability to move or sit.I have severe knee arthritis.I experience knee pain during activities like standing or walking.I have been using a prescribed knee brace for over three months.
Research Study Groups:
This trial has the following groups:- Group 1: Knee OA group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Osteoarthritis Patient Testimony for trial: Trial Name: NCT04653896 — N/A
Share this study with friends
Copy Link
Messenger